How Investors May Respond To Thermo Fisher Scientific (TMO) Expanding Access To Parkinson’s Proteomic Data
Thermo Fisher Scientific (TMO) has completed large-scale Olink Explore HT proteomic analysis on Parkinson's samples from The Michael J. Fox Foundation, making the data accessible for research. This initiative reinforces Thermo Fisher's role in precision medicine and its focus on innovation and recurring revenue. …